Connor, Clark & Lunn Investment Management (CC&L)’s Prestige Consumer Healthcare PBH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-7,319
| Closed | -$528K | – | 1581 |
|
|
2024
Q3 | $528K | Sell |
7,319
-4,211
| -37% | -$304K | ﹤0.01% | 1085 |
|
|
2024
Q2 | $794K | Buy |
+11,530
| New | +$794K | ﹤0.01% | 913 |
|
|
2023
Q4 | – | Sell |
-27,009
| Closed | -$1.54M | – | 1514 |
|
|
2023
Q3 | $1.54M | Sell |
27,009
-3,637
| -12% | -$208K | 0.01% | 690 |
|
|
2023
Q2 | $1.82M | Buy |
30,646
+27,448
| +858% | +$1.63M | 0.01% | 627 |
|
|
2023
Q1 | $200K | Sell |
3,198
-8,975
| -74% | -$562K | ﹤0.01% | 1099 |
|
|
2022
Q4 | $762K | Sell |
12,173
-23,362
| -66% | -$1.46M | ﹤0.01% | 773 |
|
|
2022
Q3 | $1.77M | Sell |
35,535
-2,871
| -7% | -$143K | 0.01% | 517 |
|
|
2022
Q2 | $2.26M | Buy |
38,406
+22,703
| +145% | +$1.33M | 0.01% | 449 |
|
|
2022
Q1 | $831K | Buy |
15,703
+8,890
| +130% | +$470K | ﹤0.01% | 696 |
|
|
2021
Q4 | $413K | Buy |
+6,813
| New | +$413K | ﹤0.01% | 833 |
|
|
2020
Q3 | – | Sell |
-28,173
| Closed | -$1.06M | – | 1072 |
|
|
2020
Q2 | $1.06M | Buy |
+28,173
| New | +$1.06M | 0.01% | 598 |
|
|
2014
Q4 | – | Sell |
-13,300
| Closed | -$431K | – | 627 |
|
|
2014
Q3 | $431K | Buy |
13,300
+3,200
| +32% | +$104K | ﹤0.01% | 412 |
|
|
2014
Q2 | $365K | Sell |
10,100
-24,500
| -71% | -$885K | ﹤0.01% | 429 |
|
|
2014
Q1 | $1.04M | Buy |
+34,600
| New | +$1.04M | 0.01% | 377 |
|